Competition experiment ([3H]SCH vs SKF38393) | Parameters | |
---|---|---|
KD1 (nm) | KD2 (nm) | |
Not treated rats in the absence of cocaine | ||
Control | 31 ± 4 | 1100 ± 200 |
+RAMH | 14 ± 1* | 320 ± 10* |
Not treated rats in the presence of cocaine | ||
Control | 28 ± 2 | 1000 ± 100 |
+RAMH | 30 ± 4 | 1100 ± 200 |
Cocaine acutely treated rats | ||
Control | 28 ± 4 | 440 ± 60 |
+RAMH | 19 ± 4 | 390 ± 40 |
Sham rats | ||
Control | 26 ± 4 | 700 ± 100 |
+RAMH | 3 ± 2** | 130 ± 40** |
Cocaine self-administered rats | ||
Control | 33 ± 6 | 800 ± 200 |
+RAMH | 37 ± 9 | 1900 ± 600 |
↵Competition curves of the D1R antagonist [3H]SCH 23390 (2 nm) binding versus increasing concentrations of the D1R agonist SKF 38393 were performed in the absence or the presence of 2 nm of the H3R agonist RAMH using striatal membranes from control rats treated or not with 30 μm cocaine for 30 min, rats acutely treated with cocaine, or cocaine self-administered rats. KD1 and KD2 are, respectively, the equilibrium dissociation constants of SKF 38393 binding to D1R and were determined by fitting binding data to Equation 3. Parameters are mean ± SEM (n = 3). For each group, significant differences with respect to control were calculated by an unpaired Student's t test (*p < 0.05, **p < 0.01).